A-A-54470
15 August 1991
COMMERCIAL ITEM DESCRIPTION
NEOMYCIN AND POLYMYXIN B SULFATES AND
HYDROCORTISONE OTIC SUSPENSION, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-N-37847 which is cancelled.
Salient Characteristics:
Shall be Neomycin and Polymyxin B Sulfates and Hydrocortizone Otic Suspension, USP.
Shall be in accordance with the requirements of the USP.
Shall be a sterile otic suspension containing in each ml:
|
Polymyxin B (as Polymyxin B Sulfates) |
10,000 units |
|
Neomycin Sulfate |
5 mg (equivalent to 3.5 mg of Neomycin base) |
|
Hydrocortisone |
10 mg (1 percent) |
The Otic Suspension should also include appropriate quantities of the following inactive ingredients: Cetyl Alcohol, Propylene Glycol, Polyssorbate 80, Water for Injection, and Thimerosol (preservative) 0.1%.
Workmanship. The suspension shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG). Shall be supplied 10 ml in a commercially available bottle with separate sterilized calibrated dropper. One package containing one bottle and one dropper, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business